Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cells
Open Access
- 21 September 2006
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 20 (10), 1889-1892
- https://doi.org/10.1038/sj.leu.2404329
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapyBlood, 2006
- Target Antigen Expression on a Professional Antigen-Presenting Cell Induces Superior Proliferative Antitumor T-Cell Responses via Chimeric T-Cell ReceptorsJournal of Immunotherapy, 2006
- Enhanced antilymphoma efficacy of CD19-redirected influenza MP1–specific CTLs by cotransfer of T cells modified to present influenza MP1Blood, 2005
- Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemiaLeukemia, 2004
- T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effectBlood, 2003
- Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15Nature Medicine, 2003
- Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BBNature Biotechnology, 2002
- The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cellsJournal of Immunological Methods, 1990